Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (291-300 of 991) with videos related to

Pageof 100
Sort By:
Diabetes, Obesity & Metabolism|April 9, 2020
Non-steroidal mineralocorticoid antagonists: Prospects for renoprotection in diabetic kidney diseaseOmar Al Dhaybi, George L Bakris
Archives of Internal Medicine|August 8, 2012
Use of a single target blood pressure level in type 2 diabetes mellitus for all cardiovascular risk reduction: comment on "intensive and standard blood pressure targets in patients with type 2 diabetes mellitus"Pantelis A Sarafidis, George L Bakris
Advances in Chronic Kidney Disease|February 24, 2015
Renal denervation for resistant hypertension and beyondLuke J Laffin, George L Bakris
Kidney International|February 1, 1985
A role for calcium in radiocontrast-induced reductions in renal hemodynamicsG L Bakris, J C Burnett
Hypertension (Dallas, Tex. : 1979)|March 20, 2024
Overview of the Evolution of Hypertension: From Ancient Chinese Emperors to TodayGeorge L Bakris, Michael A Weber
Expert Opinion on Pharmacotherapy|August 20, 2010
Hypertensive nephropathy: prevention and treatment recommendationsPeter D Hart, George L Bakris
Cardiology Clinics|July 13, 2010
Lower blood pressure goals in high-risk cardiovascular patients: are they defensible?Keith A Hopkins, George L Bakris
Current Vascular Pharmacology|May 29, 2010
Serum creatinine vs. albuminuria as biomarkers for the estimation of cardiovascular riskRigas G Kalaitzidis, George L Bakris
Nature Reviews. Endocrinology|February 9, 2011
Do fibrates truly preserve kidney function?Suneel M Udani, George L Bakris
Journal of the Cardiometabolic Syndrome|August 8, 2007
Insulin resistance, hyperinsulinemia, and hypertension: an epidemiologic approachPantelis A Sarafidis, George L Bakris
Pageof 100

Showing results (291-300 of 991) with videos related to

Sort By:
Pageof 100
Diabetes, Obesity & Metabolism|April 9, 2020
Non-steroidal mineralocorticoid antagonists: Prospects for renoprotection in diabetic kidney diseaseOmar Al Dhaybi, George L Bakris
Archives of Internal Medicine|August 8, 2012
Use of a single target blood pressure level in type 2 diabetes mellitus for all cardiovascular risk reduction: comment on "intensive and standard blood pressure targets in patients with type 2 diabetes mellitus"Pantelis A Sarafidis, George L Bakris
Advances in Chronic Kidney Disease|February 24, 2015
Renal denervation for resistant hypertension and beyondLuke J Laffin, George L Bakris
Kidney International|February 1, 1985
A role for calcium in radiocontrast-induced reductions in renal hemodynamicsG L Bakris, J C Burnett
Hypertension (Dallas, Tex. : 1979)|March 20, 2024
Overview of the Evolution of Hypertension: From Ancient Chinese Emperors to TodayGeorge L Bakris, Michael A Weber
Expert Opinion on Pharmacotherapy|August 20, 2010
Hypertensive nephropathy: prevention and treatment recommendationsPeter D Hart, George L Bakris
Cardiology Clinics|July 13, 2010
Lower blood pressure goals in high-risk cardiovascular patients: are they defensible?Keith A Hopkins, George L Bakris
Current Vascular Pharmacology|May 29, 2010
Serum creatinine vs. albuminuria as biomarkers for the estimation of cardiovascular riskRigas G Kalaitzidis, George L Bakris
Nature Reviews. Endocrinology|February 9, 2011
Do fibrates truly preserve kidney function?Suneel M Udani, George L Bakris
Journal of the Cardiometabolic Syndrome|August 8, 2007
Insulin resistance, hyperinsulinemia, and hypertension: an epidemiologic approachPantelis A Sarafidis, George L Bakris
Pageof 100